PRME vs. CRGX, RGNX, MESO, PROK, RLAY, HLVX, HUMA, KYTX, ITOS, and IMTX
Should you be buying Prime Medicine stock or one of its competitors? The main competitors of Prime Medicine include CARGO Therapeutics (CRGX), REGENXBIO (RGNX), Mesoblast (MESO), ProKidney (PROK), Relay Therapeutics (RLAY), HilleVax (HLVX), Humacyte (HUMA), Kyverna Therapeutics (KYTX), iTeos Therapeutics (ITOS), and Immatics (IMTX). These companies are all part of the "biological products, except diagnostic" industry.
Prime Medicine (NYSE:PRME) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability.
70.4% of Prime Medicine shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 24.3% of Prime Medicine shares are owned by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Prime Medicine received 7 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 72.22% of users gave Prime Medicine an outperform vote.
CARGO Therapeutics' return on equity of 0.00% beat Prime Medicine's return on equity.
In the previous week, Prime Medicine had 5 more articles in the media than CARGO Therapeutics. MarketBeat recorded 15 mentions for Prime Medicine and 10 mentions for CARGO Therapeutics. Prime Medicine's average media sentiment score of 0.62 beat CARGO Therapeutics' score of 0.45 indicating that Prime Medicine is being referred to more favorably in the media.
Prime Medicine currently has a consensus price target of $15.09, indicating a potential upside of 100.41%. CARGO Therapeutics has a consensus price target of $29.00, indicating a potential upside of 42.09%. Given Prime Medicine's higher possible upside, equities research analysts plainly believe Prime Medicine is more favorable than CARGO Therapeutics.
Summary
Prime Medicine and CARGO Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.
Get Prime Medicine News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRME and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prime Medicine Competitors List
Related Companies and Tools
